petmed express inc. - PETS

PETS

Close Chg Chg %
2.98 -0.10 -3.36%

Closed Market

2.88

-0.10 (3.36%)

Volume: 152.17K

Last Updated:

Feb 6, 2026, 4:00 PM EDT

Company Overview: petmed express inc. - PETS

PETS Key Data

Open

$3.00

Day Range

2.88 - 3.02

52 Week Range

1.57 - 5.54

Market Cap

$66.03M

Shares Outstanding

21.37M

Public Float

15.28M

Beta

0.71

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$2.65

Yield

0.00%

Dividend

$0.30

EX-DIVIDEND DATE

Aug 11, 2023

SHORT INTEREST

N/A

AVERAGE VOLUME

173.78K

 

PETS Performance

1 Week
 
-9.72%
 
1 Month
 
-13.25%
 
3 Months
 
11.63%
 
1 Year
 
-45.86%
 
5 Years
 
-91.72%
 

PETS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About petmed express inc. - PETS

PetMed Express, Inc. markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The firm provides treatments for allergies, arthritis, anxiety, dermatitis, diabetes, and heartworms. It offers access to a range of non-prescription health and wellness products and Rx food, non-Rx food, and treats. The company was founded in January 1996 and is headquartered in Delray Beach, FL.

PETS At a Glance

PetMed Express, Inc.
420 South Congress Avenue
Delray Beach, Florida 33445
Phone 1-561-526-4444 Revenue 226.97M
Industry Specialty Stores Net Income -6,271,000.00
Sector Retail Trade Employees 173
Fiscal Year-end 03 / 2026
View SEC Filings

PETS Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.38
Price to Book Ratio 1.017
Price to Cash Flow Ratio 18.29
Enterprise Value to EBITDA 3.875
Enterprise Value to Sales 0.144
Total Debt to Enterprise Value 0.031

PETS Efficiency

Revenue/Employee 1,311,976.879
Income Per Employee -36,248.555
Receivables Turnover 97.959
Total Asset Turnover 1.402

PETS Liquidity

Current Ratio 1.257
Quick Ratio 0.998
Cash Ratio 0.872

PETS Profitability

Gross Margin 27.359
Operating Margin 0.604
Pretax Margin -0.259
Net Margin -2.763
Return on Assets -3.873
Return on Equity -6.896
Return on Total Capital -7.281
Return on Invested Capital -6.839

PETS Capital Structure

Total Debt to Total Equity 1.17
Total Debt to Total Capital 1.156
Total Debt to Total Assets 0.67
Long-Term Debt to Equity 0.628
Long-Term Debt to Total Capital 0.621
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Petmed Express Inc. - PETS

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
273.42M 256.86M 281.06M 226.97M
Sales Growth
-11.58% -6.06% +9.42% -19.25%
Cost of Goods Sold (COGS) incl D&A
198.08M 189.39M 209.47M 164.87M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
2.74M 3.55M 7.06M 7.04M
Depreciation
2.74M 3.55M 5.06M 5.04M
Amortization of Intangibles
- - 2.00M 2.00M
-
COGS Growth
-10.65% -4.39% +10.60% -21.29%
Gross Income
75.34M 67.47M 71.59M 62.10M
Gross Income Growth
-13.92% -10.45% +6.11% -13.26%
Gross Profit Margin
+27.55% +26.27% +25.47% +27.36%
2022 2023 2024 2025 5-year trend
SG&A Expense
49.63M 68.90M 78.55M 60.73M
Research & Development
- - - -
-
Other SG&A
49.63M 68.90M 78.55M 60.73M
SGA Growth
-0.61% +38.83% +14.01% -22.69%
Other Operating Expense
- - - -
-
Unusual Expense
- - 1.20M 2.90M
-
EBIT after Unusual Expense
25.71M (1.43M) (8.16M) (1.53M)
Non Operating Income/Expense
1.36M 3.01M 1.89M 943.00K
Non-Operating Interest Income
335.00K 2.07M 511.00K 185.00K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
27.07M 1.58M (6.27M) (587.00K)
Pretax Income Growth
-30.97% -94.15% -496.02% +90.64%
Pretax Margin
+9.90% +0.62% -2.23% -0.26%
Income Tax
5.97M 1.35M 1.19M 5.68M
Income Tax - Current - Domestic
6.32M 2.92M 898.00K 436.00K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(345.00K) (1.56M) 293.00K 5.25M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
21.10M 233.00K (7.46M) (6.27M)
Minority Interest Expense
- - - -
-
Net Income
21.10M 233.00K (7.46M) (6.27M)
Net Income Growth
-31.05% -98.90% -3,303.43% +15.98%
Net Margin Growth
+7.72% +0.09% -2.66% -2.76%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
21.10M 233.00K (7.46M) (6.27M)
Preferred Dividends
- - - -
-
Net Income Available to Common
21.10M 233.00K (7.46M) (6.27M)
EPS (Basic)
1.0458 0.0115 -0.366 -0.3045
EPS (Basic) Growth
-31.45% -98.90% -3,282.61% +16.80%
Basic Shares Outstanding
20.18M 20.27M 20.40M 20.60M
EPS (Diluted)
1.0365 0.0115 -0.366 -0.3045
EPS (Diluted) Growth
-31.86% -98.89% -3,282.61% +16.80%
Diluted Shares Outstanding
20.36M 20.34M 20.40M 20.60M
EBITDA
28.45M 2.12M 94.00K 8.41M
EBITDA Growth
-28.90% -92.56% -95.56% +8,845.74%
EBITDA Margin
+10.40% +0.82% +0.03% +3.70%

Insider Actions for Petmed Express Inc. - PETS

Date Name Shares Transaction Value
Jul 23, 2025 Moises Tache Galante 2,575,000 Open market or private purchase of non-derivative security Non-derivative transaction at $3.5 per share 9,012,500.00

Petmed Express Inc. in the News